BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 24330091)

  • 1. Successful unrelated umbilical cord blood transplantation for class 3 β-thalassemia major using a reduced-toxicity regimen.
    Soni S; Breslin N; Cheerva A
    Pediatr Transplant; 2014 Mar; 18(2):E41-3. PubMed ID: 24330091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid and complete donor chimerism after unrelated mismatched cord blood transplantation in 5 children with beta-thalassemia major.
    Jaing TH; Hung IJ; Yang CP; Chen SH; Sun CF; Chow R
    Biol Blood Marrow Transplant; 2005 May; 11(5):349-53. PubMed ID: 15846288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treosulfan-thiotepa-fludarabine-based conditioning regimen for allogeneic transplantation in patients with thalassemia major: a single-center experience from north India.
    Choudhary D; Sharma SK; Gupta N; Kharya G; Pavecha P; Handoo A; Setia R; Katewa S
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):492-5. PubMed ID: 23160007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful unrelated cord blood transplantation in a child with beta-thalassemia major.
    Jaing TH; Hung IJ; Yang CP; Lin TY; Chow R; Hsieh SI
    J Trop Pediatr; 2005 Apr; 51(2):122-4. PubMed ID: 15840763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency.
    Al-Mousa H; Al-Shammari Z; Al-Ghonaium A; Al-Dhekri H; Al-Muhsen S; Al-Saud B; Arnaout R; Al-Seraihy A; Al-Jefri A; Al-Ahmari A; Ayas M; El-Solh H
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):818-23. PubMed ID: 20079864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unrelated donor stem cell transplantation for transfusion-dependent thalassemia.
    Shenoy S; Thompson AA
    Ann N Y Acad Sci; 2016 Mar; 1368(1):122-6. PubMed ID: 26999376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Umbilical cord blood transplantation in Chinese children with beta-thalassemia.
    Fang J; Huang S; Chen C; Zhou D; Li CK; Li Y; Huang K
    J Pediatr Hematol Oncol; 2004 Mar; 26(3):185-9. PubMed ID: 15125611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second transplant with two unrelated cord blood units for early graft failure after cord blood transplantation for thalassemia.
    Jaing TH; Hung IJ; Yang CP; Tsai MH; Lee WI; Sun CF
    Pediatr Transplant; 2009 Sep; 13(6):766-8. PubMed ID: 19067930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic stem cell transplantation from unrelated donor for class 3 beta-thalassemia major using reduced-intensity conditioning regimen.
    Zhu KE; Gu J; Zhang T
    Bone Marrow Transplant; 2006 Jan; 37(1):111-2. PubMed ID: 16258532
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk adopted allogeneic hematopoietic stem cell transplantation using a reduced intensity regimen for children with thalassemia major.
    Hussein AA; Al-Zaben A; Ghatasheh L; Natsheh A; Hammada T; Abdel-Rahman F; Abu-Jazar H; Sharma S; Najjar R; Frangoul H
    Pediatr Blood Cancer; 2013 Aug; 60(8):1345-9. PubMed ID: 23424175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful second transplantation with non-myeloablative conditioning using haploidentical donors for young patients after graft failure following double umbilical cord cell transplantation.
    Liu H; Wang X; Geng L; Tang B; Tong J; Yao W; Wang Z; Sun Z
    Pediatr Transplant; 2010 Jun; 14(4):465-70. PubMed ID: 19732379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen.
    Sanz J; Boluda JC; Martín C; González M; Ferrá C; Serrano D; de Heredia CD; Barrenetxea C; Martinez AM; Solano C; Sanz MA; Sanz GF;
    Bone Marrow Transplant; 2012 Oct; 47(10):1287-93. PubMed ID: 22327127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of unrelated umbilical cord blood transplantation for X-linked adrenoleukodystrophy.
    Beam D; Poe MD; Provenzale JM; Szabolcs P; Martin PL; Prasad V; Parikh S; Driscoll T; Mukundan S; Kurtzberg J; Escolar ML
    Biol Blood Marrow Transplant; 2007 Jun; 13(6):665-74. PubMed ID: 17531776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Directed sibling donor cord blood banking for children with beta-thalassemia major in Greece: usage rate and outcome of transplantation for HLA-matched units.
    Goussetis E; Petrakou E; Theodosaki M; Kitra V; Peristeri I; Vessalas G; Dimopoulou MN; Spiropoulos A; Papassavas AC; Stavropoulos-Giokas C; Graphakos S
    Blood Cells Mol Dis; 2010; 44(2):107-10. PubMed ID: 19931473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplantation of a child with sickle cell anemia with an unrelated cord blood unit after reduced intensity conditioning.
    Mazur M; Kurtzberg J; Halperin E; Ciocci G; Szabolcs P
    J Pediatr Hematol Oncol; 2006 Dec; 28(12):840-4. PubMed ID: 17164657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases.
    Bradley MB; Satwani P; Baldinger L; Morris E; van de Ven C; Del Toro G; Garvin J; George D; Bhatia M; Roman E; Baxter-Lowe LA; Schwartz J; Qualter E; Hawks R; Wolownik K; Foley S; Militano O; Leclere J; Cheung YK; Cairo MS
    Bone Marrow Transplant; 2007 Oct; 40(7):621-31. PubMed ID: 17660841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling.
    Lisini D; Zecca M; Giorgiani G; Montagna D; Cristantielli R; Labirio M; Grignani P; Previderè C; Di Cesare-Merlone A; Amendola G; Bergami E; Mastronuzzi A; Maccario R; Locatelli F
    Haematologica; 2008 Dec; 93(12):1859-67. PubMed ID: 18945748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fludarabine-based reduced intensity conditioning for stem cell transplantation of Fanconi anemia patients from fully matched related and unrelated donors.
    Bitan M; Or R; Shapira MY; Aker M; Resnick IB; Ackerstein A; Samuel S; Elad S; Slavin S
    Biol Blood Marrow Transplant; 2006 Jul; 12(7):712-8. PubMed ID: 16785060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic stem cell transplantation from matched related and unrelated donors in thalassemia major patients using a reduced toxicity fludarabine-based regimen.
    Resnick IB; Aker M; Tsirigotis P; Shapira MY; Abdul-Hai A; Bitan M; Gesundheit B; Amar A; Ackerstein A; Samuel S; Slavin S; Or R
    Bone Marrow Transplant; 2007 Nov; 40(10):957-64. PubMed ID: 17846604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful hematopoietic reconstitution by unrelated donor cord blood transplantation in children with Fanconi anemia: report of 3 cases.
    Jaing TH; Chen SH; Yang CP; Hung IJ; Chang TY; Hsueh C
    J Pediatr Hematol Oncol; 2014 Nov; 36(8):e553-5. PubMed ID: 25072365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.